Clinical trial Recruiting at 1 site Interventional Ages 22 to 80

VNS with Rehab to Improve Gait After Stroke

Official title: The Impact of Vagus Nerve Stimulation Paired With Rehabilitation on Lower Limb and Gait Functions After Ischemic Stroke

Run by State University of New York at Buffalo · NCT07643337 · Data updated 2026-11-12

This study tests whether adding vagus nerve stimulation to gait rehabilitation helps stroke survivors improve walking.

More Stroke trials

Quick facts

Study typeInterventional
Ages22 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorState University of New York at Buffalo
Academic / other
Locations1 site (Buffalo, New York)
StatusRecruiting
StartedJune 2026
Main results expectedDecember 15, 2027
Study endsFebruary 23, 2028
Registry record updatedJune 11, 2026
Trial IDNCT07643337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22-80 with stroke-related upper and lower limb deficits who have residual hand movement and a FAC of 3 or higher and are candidates for VNS therapy.

Probably not a fit

Patients lacking lower-limb impairment suitable for gait rehabilitation or those not benefiting from VNS in prior upper-limb rehab may not experience gait improvements.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind study will enroll stroke survivors who have both upper and lower limb deficits and are undergoing VNS-based rehabilitation. After completing the standard upper-limb VNS rehabilitation, participants are assigned to continue gait rehabilitation with the VNS device either turned on or off for the duration of therapy. Researchers will compare clinical and laboratory measures of gait and lower-limb function between the two groups to determine if VNS enhances walking recovery. The trial aims to address the lack of approved neuromodulation options for improving gait after stroke. Participants must meet FDA criteria for VNS and have residual upper-limb movement and sufficient ambulation ability to participate.

Why it matters

Potential benefit: If successful, this approach could improve gait and lower-limb function, enhancing independence and quality of life for stroke survivors.

How similar studies have gone: Prior work suggests VNS may improve upper-limb recovery; this study extends the approach to lower-limb gait and is novel in this domain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Approved for Vagus Nerve Stimulation (VNS) and rehabilitation therapy
* ≥22 years and ≤ 80 years
* Only patients who elect to undergo VNS therapy for stroke-related upper limb deficits
* Residual active movement in the affected limb's thumb and other 2 fingers
* Stroke-related deficits in the lower limbs and gait with a Functional Ambulation Category (FAC) ≥3
* Able to follow simple instructions and independently walk short distances with or without external support or leg orthoses, but without manual contact with another person

Exclusion Criteria:

* Intact lower limb functions (Fugl-Meyer score=34)
* Not a candidate for VNS therapy according to FDA guidelines
* Pregnant patients

Where it's running

  • University at Buffalo Neurosurgery
    Buffalo, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Assaf Berger, MD — University at Buffalo
  • Study coordinator: Ellen M Carl, PhD, CCRP
  • Email: ecarl@ubns.com
  • Phone: 716-218-1000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.